Arthneeti

Entero Healthcare Solutions Q1 FY27 Share Price & Earnings Call Analysis

₹1,575.20+1.02% today
Market cap
₹6,856 Cr
P/E
53.12
ROE
6.94%
PEG
0.41
Price to sales
0.97
Debt to equity
0.40
52W high / low
₹1,898 / ₹949
Sales growth (5Y)
30.03%
EBITDA margin
4.39%
Net profit margin
2.28%
Promoter holding
52.40%
Sales (last year)
₹7,128 Cr

Incorporated in 2018, Entero Healthcare Solutions Ltd is in the business of distribution and marketing of pharmaceutical and surgical products and allied services[1]

Guidance scorecard · Q1 FY27 call

What Entero Healthcare Solutions Ltd's management guided
and where it ranks in Retailing

#3of 28 in
Retailing
Revenue20–40%MarginsUp 0–2%CapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

20–40%
  • Entero Healthcare Solutions targets consolidated revenue growth of approximately 23% year-on-year for FY27, excluding any major new acquisitions.
  • The company aims to grow at an excess of 20% over the medium term (3 to 4 years), combining both organic and inorganic growth.
  • Focus for FY27 is primarily on organic growth by deepening existing relationships and expanding wallet share with current customers.
  • MedTech revenue is expected to cross INR 1,000 crores organically in FY27, contributing higher margins and growth.
  • Growth outperforming the industry (IPM) is driven by better service levels, wider product range, and stronger collaborations.

2 more points from Entero Healthcare Solutions Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Up 0–2%

See what Entero Healthcare Solutions Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Management indicates there will not be any major acquisitions in FY27 but keeps options open for smaller deals.
  • Cash generated (50% of EBITDA converted to operating cash flow after working capital) will be deployed either for acquisitions, debt reduction, or buying out minority interests, whichever best enhances EPS.
  • Depreciation levels are expected to remain steady going forward, subject to no major capex.

2 more points from Entero Healthcare Solutions Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Entero Healthcare Solutions Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • The company is focused on organic growth with no major acquisitions planned for FY27.
  • They maintain a strong and expanding distribution network with over 72,000 retail customers and 2,300 hospital customers.
  • They have significant collaborations and partnerships expanding demand generation, especially in the MedTech segment.

2 more points from Entero Healthcare Solutions Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis
Full Retailing ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Retailing
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. This stockEntero Healthcare Solutions LtdGood growth
    3
See all potential multibaggersAll Retailing rankings

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Retailing companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Flat₹6,264 Cr38.2
240%+Flat₹6,053 Cr53.9
3Entero Healthcare Solutions LtdThis stock20–40%Up 0–2%₹6,899 Cr53.5
420–40%Up 0–2%₹790 Cr19.0
520–40%Flat₹3.14L Cr725.0
620–40%Flat₹1.12L Cr170.8

Sign up free to see every company in the sector ranking and track Entero Healthcare Solutions Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Retailing ranking

Financials of Entero Healthcare Solutions Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Entero Healthcare Solutions Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +8878999969931,0341,0971,3011,3591,3391,4041,5711,7071,910
Expenses +8678739689641,0051,0671,2581,3091,2901,3541,5091,6391,824
Operating Profit20262929293042504950626886
OPM %2%3%3%3%3%3%3%4%4%4%4%4%4%
Other Income +1122913118765-44
Interest13141816171011101011121417
Depreciation7666777889101015
Profit before tax1778142735393736454058
Tax %490%6%23%16%-56%25%25%25%16%17%18%16%22%
Net Profit +-4657212126293130373445
EPS in Rs-9.0515.183.194.224.824.625.435.855.906.397.266.356.44

Financials of Entero Healthcare Solutions Ltd

Profit & Loss

Annual income statement trend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +1,3501,7732,5223,3003,9225,0966,591
Expenses +1,3261,7582,4983,2363,8104,9246,325
Operating Profit23152464112172266
OPM %2%1%1%2%3%3%4%
Other Income +51146143911
Interest13202949664254
Depreciation12162024253143
Profit before tax4-11-20-436139179
Tax %67%42%49%201%-12%23%19%
Net Profit +1-15-29-1140107146
EPS in Rs93.81-1,550.90-77.71-28.128.9921.7926.44
Dividend Payout %0%0%0%0%0%0%0%

Financials of Entero Healthcare Solutions Ltd

Balance Sheet

Capital structure and asset base

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.100.1044434444
Reserves-16-32-62-731,5951,6811,645
Borrowings +6037209741,101338385677
Other Liabilities +1621472102753695931,234
Total Liabilities7498361,1251,3082,3452,7033,600
Fixed Assets +186189262268289559960
CWIP2210000
Investments0000058130
Other Assets +5606458631,0402,0562,0852,510
Total Assets7498361,1251,3082,3452,7033,600

Financials of Entero Healthcare Solutions Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-37-69-35-45-37-7796
Cash from Investing Activity +-203-31-162-49-704232-303
Cash from Financing Activity +2178921173863-74124
Net Cash Flow-23-1114-2112282-83
Free Cash Flow-81-78-45-51-41-8729
CFO/OP-134%-430%-100%-51%-21%-23%36%

Financials of Entero Healthcare Solutions Ltd

Ratios

Working capital efficiency and return ratios

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days63505457575967
Inventory Days57544941435252
Days Payable32222225243145
Cash Conversion Cycle88828173778074
Working Capital Days57544132486542
ROCE %1%1%5%7%9%11%

Guidance history

How Entero Healthcare Solutions Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%Up 0–2%Planned——
Q3 FY26 call →20–40%Up 0–2%PlannedNone planned—
Q2 FY26 call →20–40%Up 0–2%PlannedPlanned—

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

84out of 100

Momentum score · price trend

84 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+42.2%83%
Last 6 months+29.5%81%
Last 3 months+26.6%91%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Entero Healthcare Solutions Ltd: 0.4 × 83 + 0.4 × 81 + 0.2 × 91 = 84.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Entero Healthcare Solutions Ltd's management said in earlier quarters

Others in Retailing this season

  • Aditya Birla Lifestyle Brands Ltd (Q2 FY27)

    2,266 Cr, up 11% YoY from Rs. Key investor presentation takeaways from Aditya Birla Lifestyle Brands Ltd's Q2 FY27 investor presentation — and how it ranks agai

  • Digidrive Dist. (Q2 FY27)

    1,024 lakhs in the same quarter of 2025, representing a year-on-year increase of approximately 34.4%. Key results statement takeaways from Digidrive Distributor

  • Crizac Ltd (Q2 FY27)

    Q2 FY27 Operating Income (Revenue):** ₹1,027 million . Key investor presentation takeaways from Crizac Ltd's Q2 FY27 investor presentation — and how it ranks ag

  • Aditya Vision (Q2 FY27)

    586 Cr, up 28.1% YoY from Rs. Key investor presentation takeaways from Aditya Vision Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers

Compare:vs Eternalvs Avenue Super.vs Trent Ltd